NHLBI-funded studies published by The New England Journal of Medicine provide additional support for intensive blood pressure control in patients with high risk of cardiovascular disease. The study about the cost-effectiveness of this approach “is important not just because it shows that the long-term benefits of intensive blood pressure treatment outweigh considerations about costs and side effects, but because of its population-wide implications,” said co-author Lawrence Fine M.D., Dr.P.H., Chief of the Branch of Clinical Applications and Prevention at NHLBI. The authors of the study on patient-reported outcomes found that intensive blood pressure treatment appeared to be safe and well tolerated.
- Health Topics
- Health Education
- The Science
- Grants and Training
- News and Events
- About NHLBI